Six-month (orlistat) xenical therapy of patients with stable angina pectoris concomitant with obesity and hyperlipemia

Terapevticheskii Arkhiv

Volumn 74, Issue 1, 2002, Pages 47-51

  Naumov, V G ^a   Lupanov, V P ^a   Dotsenko, Yu V ^a   Tvorogova, M G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; HYPOCHOLESTEROLEMIC AGENT; LACTONE; LIPID; TETRAHYDROLIPSTATIN;

AGED; ANGINA PECTORIS; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; EXERCISE TEST; FEMALE; HUMAN; HYPERLIPIDEMIA; MALE; MIDDLE AGED; OBESITY; RANDOMIZED CONTROLLED TRIAL;

AGED; ANGINA PECTORIS; ANTI-OBESITY AGENTS; ANTICHOLESTEREMIC AGENTS; EXERCISE TEST; FEMALE; HUMANS; HYPERLIPIDEMIAS; LACTONES; LIPIDS; MALE; MIDDLE AGED; OBESITY;

EID: 0036364482     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Stevens J., Cai J., Pamuk E. R. et al. The effect of age on the association between bofy-mass index and mortality. N. Engl. J. Med. 1998; 338: 1-7.
2. Garrison R. J., Higgins M. W., Kannel W. B. Obesity and coronary heart disease. Curr. Opin. Lipidol. 1996; 7: 199-202.
3. Van Gaal L. F., Zhang A., Sieijaert M. M. et al Human obesity: from lipid abnormalities to lipid oxidation. Int J. Obesity 1995; 19: 521-526.
4. Hill J, O., Hauptman J., Anderson J. W. et al. Orlistat, a lipase inhibitor, for weight maintenancer after conventional dieting: a I-y study. Am. J Clin. Nutr. 1999; 69: 1108-1116.
5. Van Gaal L. F., Broom J. I., Enzi G. et al. Efficacy and tolerability of orlistat in the treatment of obesity: a 6-month doseranging study. Eur. J. Clin. Pharmacol. 1998; 54: 125-132.
6. Hauptman J. B., Jennet F. S., Hartmann D. Initial studies in humans with the novel gastrointestinal lipase inhibitor ro-180647 (tetrahydrolipstatin). Am J. Clin. Nutr. 1992; 55(suppl. S): 309-313.